Phenomorphan
Phenomorphan is a synthetic opioid analgesic, belonging to the larger family of opioid drugs. Despite its potent analgesic properties, it is not employed in current medical practice. However, understanding its pharmacological properties, structural activity relationship, and its relation to other opioids can provide insights into drug development and opioid pharmacology.
Historical Context[edit | edit source]
Opioid analgesics have been in use for centuries, primarily derived from the poppy plant. The need for potent and effective pain relief, coupled with attempts to reduce side effects, has driven the synthesis of various opioids, including Phenomorphan.
Pharmacodynamics and Mechanism of Action[edit | edit source]
Phenomorphan exerts its analgesic effects through its interaction with the μ-opioid receptor. The presence of the N-phenethyl group in its structure significantly enhances its affinity to this receptor.
- Its potency is roughly 10 times that of levorphanol, which itself possesses a potency 6-8 times greater than morphine, a widely recognized opioid benchmark[1].
- Other analogs of Phenomorphan, in which the N-(2-phenylethyl) group has been substituted with different aromatic rings, have demonstrated even greater potency. Specifically, the N-(2-(2-furyl)ethyl) and the N-(2-(2-thienyl)ethyl) analogues are found to be 60 times and 45 times more potent than levorphanol, respectively[2].
Clinical Profile and Side Effects[edit | edit source]
Like other opioids, Phenomorphan is associated with a range of side-effects, which include:
- Itching.
- Nausea.
- Respiratory depression, which can be life-threatening in overdose scenarios.
Despite its potency and potential therapeutic value, Phenomorphan is not employed in contemporary medical treatments due to concerns over its side-effect profile and the availability of safer alternatives.
Conclusion[edit | edit source]
Phenomorphan offers an illustrative example of how chemical modifications can significantly enhance the potency of opioids. Its potent interaction with the μ-opioid receptor, because of structural attributes, highlights the intricate balance between desired therapeutic effects and unintended adverse reactions. While not in medical use, it stands as a testament to the complexities of drug development and the need for thorough evaluation of potential therapeutic agents.
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD